Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpuraMatthieu Jestin, Paul Coppo, Claire Presne et al.|Blood|2018Cited by 163
Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survivalRenaud Prével, Paul Coppo, Claire Roubaud‐Baudron et al.|Blood|2019Cited by 61
Immune‐mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressureAdrien Joseph, Paul Coppo, Martin Eloit et al.|Research and Practice in Thrombosis and Haemostasis|2022Cited by 7